Ikena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It ‘Disappointing’
Ikena Oncology halts its IK-930 program after reviewing clinical data and resources, focusing on the novel MEK-RAF molecular glue, IK-595.
Taylor Swift’s Favorite Sneaker Brand Is Going Public: Golden Goose Boasts $3.3B Valuation
Golden Goose compared to Crocs (valued at around $10 billion) and Skechers (valued at around $10 billion).
Nvidia’s Stock Jumps 7% Past $1,100 With A Boost From Elon Musk As AI Technology Continues To Drive Market Trends
Nvidia's stock surged 7% to a new high of $1,139 following a $6 billion Series B funding announcement by Elon Musk's AI startup, xAI.
Nvidia’s stock has seen a 32% increase in May and a 131% rise year-to-date.
Their 10-for-1 stock split is scheduled for June 10.
Dick’s Sporting Goods Raised Outlook After Strong Q1 Earnings, But Analyst Is Watching For Inventory Shrink Commentary
Goldman Sachs analyst Kate McShane reiterated a Buy rating on the shares of Dick's Sporting Goods. According to the analyst, the stock gained due to the earnings beat and higher 2024 guidance.
FDA Conditionally Approves Eli Lilly’s Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
Accelerated FDA approval for Eli Lilly's selpercatinib (Retevmo) in pediatric patients aged 2+ with advanced/metastatic thyroid cancer & solid tumors carrying RET mutations or fusions.
Riot Platforms May Over Power Marathon Digital As Largest Publicly Traded Bitcoin Miner – Analyst Explains How
Riot Platforms aims to become the largest publicly traded Bitcoin miner by acquiring Bitfarms, expanding its power capacity and geographic reach. ROTH MKM analyst Darren Aftahi reiterated a Buy rating on Riot Platforms with a price forecast of $20.
Restaurant Chain Cava Is ‘Positioned To Sustain Positive Transaction Growth,’ Analyst Says
Experience robust growth with CAVA Group Q1 revenue surges 30.3% YoY, surpassing estimates. Wedbush maintaining an Outperform rating.
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations.
Former Goldman Sachs Exec Beth Hammack Chosen As Next President Of Cleveland Fed
Meet Beth Hammack, the incoming President & CEO of the Federal Reserve Bank of Cleveland. With 30+ years in finance, including roles at Goldman Sachs.
What’s Going On With Accenture Stock Today?
Accenture Song secures a key role with Randstad, focusing on marketing transformation and AI-driven content creation.